Domestic pharma sales pick up in September, but not enough to lift Q2 sales

Despite witnessing a late recovery in September, domestic pharma sales moderated sequentially in Q2, which is likely to put pressure on the July-September earnings of drugmakers

Related Keywords

India , ,Motilal Oswal Financial Services ,Kotak Institutional ,Oswal Financial Services ,Pharma Market ,Alkem Laboratories ,Uipm ,2 ,Pharma Sales ,Pharmaceuticals ,Revlimid ,Q2 Earnings ,2 Results ,Harma Q2 Earnings ,Harma Q2 Results ,Omestic Pharma Sales ,Indian Pharma Market ,